Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IKT compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
IKT
Inhibikase Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
IKT
Inhibikase Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
IKT, solid
AMGN, dashed
Supply-chain overlap
Revenue flow
IKT: latest quarter is a loss; flow not drawable.
Method
›
IKT
Inhibikase Therapeutics, Inc.
Change
1.49
▼
−3.25%
· post 1.49
Mkt cap
$214.9M
Revenue
$79,569
Q3 FY23
Revenue
—
AMGN
Amgen Inc
Change
460.67
▼
−1.03%
· post 456.16
Closed
Nov 3 '26
Mkt cap
$249.4B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 3 '26
IKT
Inhibikase Therapeutics, Inc.
vs
AMGN
Amgen Inc
1.49
▼
−3.25%
post 1.49
Price
460.67
▼
−1.03%
post 456.16
$214.9M
Mkt cap
$249.4B
Q3 FY23
$79,569
Revenue
$10.1B
Q2 FY26
—
Revenue
$36.8B
FY25
Change
Change
IKT
1.49
▼
−3.25%
vs
AMGN
460.67
▼
−1.03%
Closed
Nov 3 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IKT
0
None
Shared
0
No disclosed counterparties: IKT.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Role chip = supplier or customer
Source: SEC EDGAR